In this study, the effects of nicotine on global gene expression of cultured cells from the brainstem of spontaneously hypertensive rat (SHR) and normotensive Wistar Kyoto (WKY) rats were evaluated using whole-genome oligoarrays. We found that nicotine may act differentially on the gene expression profiles of SHR and WKY. The influence of strain was present in 321 genes that were differentially expressed in SHR as compared with WKY brainstem cells independently of the nicotine treatment. A total of 146 genes had their expression altered in both strains after nicotine exposure. Interaction between nicotine treatment and the strain was observed to affect the expression of 229 genes that participate in cellular pathways related to neurotransmitter secretion, intracellular trafficking and cell communication, and are possibly involved in the phenotypic differentiation between SHR and WKY rats, including hypertension. Further characterization of their function in hypertension development is warranted.
Introduction
The central nervous system may influence the development of hypertension, 1 which is a multifactorial disease involving the participation of differentially expressed genes in the brain of hypertensive and normotensive subjects. 2 Neurogenic hypertension might be a consequence of the abnormal function of the autonomic nervous system, which may be caused by a number of external and/or intrinsic factors such as the renin-angiotensin system, insulin resistance, dietary salt sensitivity, stress and genetic factors, 3 as well as nicotine exposure. 4 Spontaneously hypertensive rats (SHR) are a good model to study neurogenic hypertension because they share similarities to human essential hypertension, 5 such as the development of hypertension in the early adult life. 6 We have earlier reported that nicotine treatment is able to intensify and accelerate the development of hypertension in prehypertensive SHR, without having much effect on normotensive Wistar Kyoto (WKY) rats, 7 which may be of relevance to the understanding of the mechanisms involved in the onset of hypertension.
Brain nuclei predominantly involved in central cardiovascular control are located especially in the brainstem. These areas are also recognized to have a relevant function in the development of hypertension.
The nucleus of the solitary tract (NTS), located at the dorsal portion of the medulla oblongata, is the major integrative site of cardiovascular information. 10, 11 Although peripheral afferent input is very important for the baroreceptor reflex, the NTS also receives a vast array of projections coming from the spinal cord, the lower brainstem and from the forebrain areas such as hypothalamus, limbic system and cerebral cortex, [12] [13] [14] which makes the cardiovascular control an elaborated circuitry.
Blood pressure control is also accomplished by other brainstem sites such as the rostro-and caudo-ventrolateral medulla oblongata (RVLM and CVLM), dorsal motor nucleus of the vagus, area postrema and locus coeruleus (in pons). 8, [15] [16] [17] We have recently shown that nicotine is able to interfere with the glutamatergic and angiotensinergic neurotransmission system preferentially in SHR as compared with WKY rats, 7, 18 indicating a possible function of nicotine in interacting with neurotransmitter systems, which might contribute to the development of hypertension.
Glutamatergic and angiotensinergic are not the only neurotransmitter systems altered in SHR, but other systems are also possibly involved in strain differences between SHR and WKY rats, related or not related to the development of hypertension. [19] [20] [21] High-density oligoarrays allow the simultaneous measurement of global gene expression levels and is a valuable tool to study pathologies associated to the central nervous system. [22] [23] [24] In this study, we aimed to evaluate the effects of nicotine exposure on gene expression of cultured neurons and glia from pons and medulla oblongata of newborn SHR and WKY rats using whole-genome oligoarrays.
Materials and methods

Cell cultures and nicotine treatment
All the procedures were approved by the Institutional Committee for animal care of the Institute of Biosciences, University of Sao Paulo. Cell culture methodology was described in details elsewhere. 25 Briefly, pons and medulla oblongata of 1-day old SHR and WKY rats (n ¼ 20 for each strain) from the animal facilities of the Department of Physiology, Institute of Biosciences, University of Sao Paulo were dissected out and dissociated in cold isotonic salt solution, pH 7.4. Cells were suspended in Neurobasal A media (Invitrogen) supplemented with L-glutamine (250 mmol l -1 , Sigma), glutamax (250 mmol l -1 , Gibco), B27 (2%, Gibco) and gentamicin (40 mg l -1 , Gibco). Viable cells were counted and plated on poly-D-lysine-coated culture dishes (35 mm, Nunclon, USA) at the concentration of 1800 cells mm -2 . Cultures were kept in a humidified incubator with 5% CO 2 /95% air, at 37 1C, for 9 days before nicotine exposure.
Cultured cells (n ¼ 3 from each strain) were treated with 10 mM of nicotine (Sigma), diluted in fresh culture medium, over 24 h. Cell cultures (n ¼ 3) kept for the same period of time in fresh medium without nicotine were used as control. The three plates of each group were polled to obtain one sample. The experiment was repeated three times using different pools of animals. At the end of the treatment, cells from SHR or WKY animals, treated or untreated with nicotine, were lysed for total RNA extraction.
RNA extraction
Total RNA was extracted according to the manufacturer's instructions using the RNAspin Mini Kit (GE Healthcare, UK). The RNA was purified and treated with DNAse before the assessment of its concentration and quality by spectrophotometry and agarose gel electrophoresis, respectively.
Target labeling and microarray hybridizations
Global measurements of gene expression in cells from normotensive and hypertensive rats after the exposition to nicotine and their controls were obtained using the CodeLink Expression Bioarray System (GE Healthcare), which interrogates 34 000 annotated genes and expressed sequence tags expressed in the rat genome. Three different samples of the each group were used in microarray hybridization constituting three biological replicates.
Target labeling and hybridization was performed strictly as recommended by the array manufacturer (GE Healthcare). In brief, the purified and high-quality total RNA was used in reverse transcription reactions to convert messenger RNA (mRNA) in double-stranded cDNA before biotin labeling. cRNA was synthesized by in vitro transcription of cDNA and simultaneously labeled with biotin-NTP mix. The samples were filtered to recover biotinylated cRNA. Assessment of cRNA concentration, purity and quality was carried out using the Agilent 2100 Bioanalyzer (Agilent Technologies, CA, USA). All the samples presented high quality and purity (260/280 ratio of 2.0).
Labeled cRNA targets were fragmented at 94 1C for 20 min before hybridization with arrays at 37 1C during 18 h. After the hybridization, the bioarrays were washed and bound targets were detected after incubation with Cy5-Streptavidin (GE Healthcare). The bioarrays were washed, dried and protected from light. All samples were processed in parallel and the arrays were incubated simultaneously using the same working solution to limit technical variation across the experiments. After the hybridization, bioarrays were scanned immediately in a GenePix 4000B scanner (Molecular Dynamics, USA).
Analysis of microarray data
CodeLink Expression Analysis software (GE Healthcare) was used to extract background-subtracted spot intensities from microarray images. Measurements that were below the intensity of negative controls plus 2 s.d. were excluded and 23 814 genes with valid measurements in all three biological replicates of brainstem cells from normotensive or hypertensive animals cultured in the presence or absence of nicotine were further analyzed. To make experiments comparable, intensity data from different hybridizations were normalized by the quantile method. 26 A two-way analysis of variance (ANOVA) was applied (PowerArray software v 1.1, National Institutes of Statistical Sciences) to identify changes in gene expression correlated to each of the experimental variables (strain and nicotine treatment), as well as resulting from the interaction between the two variables. A statistical significance threshold of at least 5% (Po0.05) was used. In addition, a fold-change (in log2 transformed data) filter was applied to exclude genes with alterations below the threshold of 0.14 for strain (SHR vs WKY) and treatment (nicotine treated vs untreated cells) comparisons. This was carried out to exclude a set of genes that did not change at all, but appeared in the borderline between those upregulated and downregulated by 0.14-fold, probably because of intrinsic statistical errors. After identifying by comparing the level of expression among groups, those genes were excluded from the final list. For interaction analysis, genes displaying concordant expression changes between nicotine-treated SHR vs untreated WKY cells or nicotine-treated WKY vs untreated SHR cells were also filtered. Gene expression heat maps were generated using the ClusterTreeView software 27 and presented as Supplementary material on The Pharmacogenomics Journal website (http://www.nature.com/tpj). Pathway enrichment within the selected gene set was evaluated using the EASE software, 28 considering a cutoff P-value of 0.05 determined by the Fisher's exact test.
Raw and normalized microarray intensities were deposited in the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE13311.
Real-time PCR
Real-time RT-PCR was used to measure the relative expression of five genes randomly chosen within the gene set selected after microarray analysis. The same RNA samples tested in microarray experiments were used and each reaction was carried out in triplicate.
Briefly, to 1 mg of total RNA, we added TaqMan buffer (1 Â ), MgCl 2 (5.5 mM), dNTPs (500 mM), random hexamers (2.5 mM), RNAse inhibitor (0.4 U ml -1 ) and the MultiScribe reverse transcriptase (1.25 U ml -1 ) to a final volume of 50 ml. Two control samples were used in the assay: one without the template and another without reverse transcriptase. RNA was converted into cDNA after incubations of 10 min at 25 1C followed by 30 min at 48 1C and 5 min at 95 1C in a thermocycler. cDNA was kept at À80 1C until its use for real-time PCR.
Primers, probes and reagents for real-time PCR were obtained from Applied Biosystems (TaqMan) (Foster City, CA, USA). Evaluated mRNAs were fibronectin 1 (TaqMan assay: Rn00692652_m1); guanylate cyclase 1 soluble beta 3 (Gucy1b3; TaqMan assay: Rn01769694_m1); Map kinase 8-interacting protein (Mapk8ip; TaqMan assay: Rn00587215_m1); cAMP responsive element modulator (Crem; TaqMan assay: Rn00578829_g1) and Adducin 3 (Add3; TaqMan assay: Rn00580668_m1). Protocol provided by the manufacturer was rigorously followed in which 12.5 ml of 2 Â PCR Master Mix, 1.25 ml of primers/probe and 6.25 ml of DEPC water were added to 5 ml of experimental cDNA. Real-time PCR system was from Applied Biosystems (7700, ABI Prism, Foster City, CA, USA). The expression of 18S rRNA was also measured using real-time RT-PCR technique (Applied Biosystems, Foster City, CA, USA) and used as internal control to normalize the results across the tested samples using the 2 ÀDDCT method. 29 For each gene, the level of expression is presented as fold change relative to the expression of WKY control, which was set to 1.
Each primer and probe was tested in five serial dilutions of template to verify their efficiency, which was approximately 100% for all the primers used in this study, including the 18S rRNA.
Real-time PCR results were analyzed by two-way ANOVA followed by the Bonferroni post-test accessed through GraphPad Prism (GraphPad Software Inc., version 3.00, CA, USA). A P-value p0.05 was considered to indicate statistically significant differences of expression among groups. Data are expressed as mean ± s.d..
Expression of candidate genes in young adult rats Adrenomedullin (Adm; TaqMan assay ID: Rn00562327_m1), angiopoietin2 (Agpt2; TaqMan assay ID: Rn01756774_m1) and vascular endothelial growth factor B (Vegfb; TaqMan assay ID: Rn01454585-g1) mRNAs were evaluated by realtime PCR, as described in the earlier section, in the same areas used for cell cultures (NTS and VLM) of 1-month-old WKY and SHR rats treated either with nicotine or placebo (n ¼ 3 of each group) delivered subcutaneously through pellets (Innovative Research of America, OH, USA) at a rate of 8 mg kg À1 per day during 10 days. This treatment with nicotine increases blood pressure level only in prehypertensive SHR. 7 
Results
Influence of rat strain on gene expression of brainstem cells To identify genes differentially expressed between SHR and WKY rats unrelated to nicotine exposure, we compared gene expression profiles from cultured brainstem cells from each strain treated or not treated with nicotine. It was found that 321 genes differentially expressed between cells from the brainstem of SHR and WKY at a significance P-value of 0.001, according to two-way ANOVA (Table 1 ; Supplementary Figure S1 ). As the rat genome is not yet fully annotated, several altered transcripts (79 out of 321) are represented by expressed sequence tags, and there is no information available regarding their function.
There is equilibrium between downregulated (176 genes) and upregulated (145 genes) genes in cells from the brainstem of SHR as compared with WKY.
Some of the genes downregulated in SHR may be involved in cardiovascular regulation such as the Adrbk2, homer2 and Gucy1b3 that are part of the adrenergic, glutamatergic and nitrergic systems, respectively. Others, such as the Agtrap, which is a component of the angiotensinergic system, are upregulated in cells from the brainstem of SHR. 
Nicotine regulates gene expression of brainstem cells
In addition to genes that participate in cardiovascular control, we found genes associated with apoptosis (Bcl2, TGF-beta-induced apoptosis protein 2); growth factors (FGF receptor 2, FGF12, TNF receptor-associated factor 6, TNF receptor-associated protein 1) and intracellular trafficking (kinesins 1B, 21A, C2, dynamin 2, Rab4b, Rab8b) that are also differentially expressed between strains. Gene ontology analysis indicated 19 molecular pathways that are enriched among genes differentially expressed between SHR and WKY cells ( Table 2) .
Influence of nicotine treatment on gene expression of brainstem cells Treatment with 10 mM of nicotine for 24 h induced strainindependent expression changes in 146 genes (Po0.01, twoway ANOVA) as illustrated in Table 3 and Supplementary Figure S2 . From the total of genes with altered expression, there are 36 expressed sequence tags. Interestingly, about 25% of the total genes were downregulated, whereas 75% had the expression augmented after nicotine exposure. This result is in agreement with a recent study that described pronounced number of genes upregulated in comparison to total downregulation in the ventral tegmental area, nucleus accumbens, prefrontal cortex and amygdala of mice treated with nicotine. 30 Among the genes differentially expressed after nicotine treatment of cultured brainstem cells of newborn SHR and WKY rats, we found the Adm receptor and Angpt2, whose expression are increased, and the Vegfb that is downregulated. Besides these genes, which are probably involved in cardiovascular regulation, the Aanat (Arylalkilamin N-acetyltransferase), Bcl2, Rab24 and solute carriers (families 4, 12, 22 and 25) were also altered in brainstem cells after nicotine exposure.
The analysis of enriched pathways indicated the prevalence of genes related to regulation of transcription and signaling routes (Table 4) , which reinforces the notion that nicotine may exert its effect by affecting the gene expression levels of specific molecular pathway components.
Interaction between strain and nicotine treatment on brainstem gene expression Gene expression in cultured brainstem cells can be highly influenced by the interaction between treatment with nicotine and strain of rats from where cells were dissociated. We found 229 genes differentially expressed between SHR and WKY after exposure to 10 mM of nicotine for 24 h (Po0.05, two-way ANOVA) ( Table 5 ; Supplementary Figure  S3 ). From these, there are 91 genes that are downregulated in WKY, but upregulated in SHR after nicotine exposure, and 138 genes upregulated in nicotine-treated WKY, but downregulated in nicotine-treated SHR cells. Seventy out of the 229 differentially expressed genes are partial transcripts from uncharacterized genes represented by expressed sequence tags.
Further analysis of differentially expressed genes between the strains after nicotine may be of relevance, as these are potential candidates to the development of hypertension in the hypertensive strain, because of the divergent physiological actions of systemically derived nicotine on WKY and SHR. For instance, Add3, dopamine beta hydroxylase, dynamin 3, fibroblast growth factor 8, interleukin receptor beta 2 and amyloid precursor protein family B member 2 are increased in WKY cells after nicotine exposure, whereas SHR cells presented decreased expression of these genes. On the other hand, epsin 1, GABA A receptor subunit gamma3, hippocalcin, interleukin 1, kinesin 1B and piccolo isoform 1 had their expression decreased in cells from WKY and increased in SHR after treatment with nicotine.
As shown in Table 6 , molecular/cellular pathways enriched within genes modulated by nicotine according to strain are mainly involved in neurotransmitter secretion, intracellular trafficking and cell communication. The decrease in significance level considered in the analysis of strain and treatment influence on gene expression (Po0.001 and Po0.01, respectively), instead of applying Po0.05 as used in interaction analysis, may be indicative of the relevance of each factor for gene expression, which might contribute to phenotype differentiation between SHR and WKY. Rat strain by itself seems to be the more influencing factor for gene expression differences, followed by treatment with nicotine and interaction between treatment and strain. Table 7 summarizes microarray data showing the total number of genes altered in cultured brainstem cells by influence of either rat strain, nicotine exposure or the interaction between these two factors.
Validation of microarray results by real-time RT-PCR
To confirm the expression data obtained using oligoarray, we evaluated the expression of five randomly chosen genes (fibronectin 1, Gucy1b3, MapK8ip, Crem and Add3) by realtime PCR (Figure 1 ). These included genes upregulated (Fn 1) or downregulated (Gucy1b3) in SHR as compared with WKY, but not affected by nicotine exposure, a gene downregulated on nicotine exposure in both strains (MapK8ip), as well as two genes (Crem and Add3) with expression apparently influenced by the interaction between strain and nicotine treatment. Basal levels of Crem measured in untreated SHR were lower as compared with untreated WKY cells. Nicotine exhibited contrasting effects in the two strains; it decreased Crem levels in WKY and increased its expression in cells from SHR. Conversely, basal levels of Add3 were higher in untreated SHR cells as compared with untreated WKY. Nicotine exposure increased Add3 relative levels in WKY and decreased it in SHR.
The expression results obtained by real-time PCR for all five genes tested were consistent with the CodeLink Bioarray analysis, which allow us to conclude that most differences in gene expression between SHR and WKY cells in the presence or absence of nicotine detected in the microarray hybridizations are reliable and accurate.
Expression of candidate genes in the brainstem of nicotinetreated rats Besides the validation using the same RNA samples isolated from cultured brainstem cells and hybridized to the microarrays, we sought to confirm the nicotine-induced modulation of candidate genes in the brainstem dissected from animals exposed to the drug. To that end, young adult SHR and WKY rats were exposed to nicotine and the expression of Adm, Agpt2 and Vegfb, which are possibly involved in the development of smoking-associated hypertension, were analyzed in the NTS and VLM.
By means of real-time PCR, it was showed that SHR express about 30% less Adm than WKY in the cardiovascular brain areas, and that exposure to nicotine increased the levels of Adm transcripts in both strains, but more expressively in the hypertensive strain (Figure 2 upper  panel) . Thus, the expression of Adm is influenced by the strain, nicotine treatment and the interaction between treatment and rat's genetic background.
We observed that the abundance of Angpt2 and Vegfb mRNAs was also influenced by the interaction between the rat strain and the treatment with nicotine as shown in Figure 2 (middle and lower panels). The transcript levels of Angpt2 and Vegfb are unaltered in SHR as compared with WKY in the untreated animals, and are upregulated in the brain cardiovascular areas of the hypertensive strain only.
Although the number of candidates tested in brainstem from young adult rats was small, this independent validation suggests that the global gene expression changes detected in the microarray experiments are not restricted to newborn animals or cultured brainstem cells. 
Nicotine regulates gene expression of brainstem cells Discussion
This study was designed to investigate global gene expression changes induced by nicotine exposure in cultured brainstem cells isolated from normo and hypertensive rats, aiming at identifying candidate genes possibly related to the development of hypertension and their possible modulation by nicotine. Nicotine modulation of gene expression and the differences in the pattern of gene expression in neural cells are already known. 30, 31 In addition to identifying genes differentially expressed between strains and within each strain on exposure to nicotine, we also investigated the possible interaction between strain and nicotine treatment in modulating gene expression.
In vitro studies are fundamental to determine the direct effects of drugs on the cell physiology, as there is the possibility to identify the molecular basis of the action and to target specific pathways. 32 However, it should be noted that the results achieved using cultured brainstem cells from newborn animals described here may not necessarily reflect all the changes that would occur in the adulthood. Likewise, changes not detected in newborn rats can be present in hypertensive adult rats subjected or not subjected to nicotine exposure. As the system in vitro may not represent the real responses that would be encountered in vivo, studies in cultured cells are often combined with experiments carried out in the intact organism. For this reason, we sought to evaluate the expression of a subset of candidate genes potentially relevant to hypertension development, such as the Adm, Agpt2 and Vegfb in the brainstem of young adult rats treated with nicotine.
Although several genes involved in blood pressure control are differentially expressed with the interaction between strain and nicotine, there are other systems that may be of relevance to study the SHR phenotype as compared with WKY rats, such as the intracellular trafficking (neurotransmitter secretion, microtubule cytoskeleton, vesiclemediated transport) that constitutes a new option to the analysis of neurotransmission.
In a recent study from our group, we described intrinsic alterations in gene expression in cultured brainstem cells and in freshly dissected brainstem tissue from newborn SHR and WKY rats. 33 Interestingly, the majority of genes encountered in this study, which may be associated or not associated with the development of hypertension, was also identified earlier in the comparison of strains. This result indicates that the most robust transcriptional differences observed between SHR and WKY strains are retained after nicotine treatment.
We have shown the influence of nicotine in regulating gene expression, which may be of relevance to the understanding of hypertension development in individuals exposed to nicotine. For instance, the Adm receptor and angiopoietin 2 are augmented and the Vegfb is decreased in cultured brainstem cells after nicotine exposure independently of the rat strain.
Adm receptor is distributed throughout the central nervous system, including the brainstem in which it participates in the cardiovascular control together with glutamate and nitric oxide inhibiting baroreflex. 34 The present microarray results indicate that nicotine increases the expression of Adm receptor in cells from both strains of rats. In agreement with the in vitro results, WKY and SHR rats treated with nicotine presented increased expression of Adm, which may contribute to the elevation of blood pressure, 35 especially in the hypertensive strain. Angiopoietin 2, an angiogenic factor, has been assigned as a predictive biomarker of cardiovascular diseases, 36 as its circulating level is increased in hypertensive patients just before myocardium infarction. Considering that nicotine abuse is an important risk factor to the development of cardiovascular diseases, nicotine-treated cultured brainstem cells and SHR rats express increased angiopoietin 2 after treatment with nicotine indicating, therefore, a possible relationship between these two molecules and the development of hypertension. The other angiogenic factor, the VEGFb, which is neuroprotective and neurogenic, 37 was decreased in cultured brainstem cells from both strains after nicotine exposure. On the other hand, nicotine-treated young adult SHR express increased levels of Vegfb in cardiovascular brain areas, which may be a response to the increased blood pressure that affects only the hypertensive strain.
Besides these genes related to blood pressure control, nicotine also modulates genes involved in other physiological processes, such as the biological rhythm (increasing the expression of Aanat-arylalkylamine N-acetyltransferase), anti-apoptosis (increasing the expression of Bcl2) and intracellular transport (increasing or decreasing Rab24, solute carrier families 4, 12, 22 and 25). Further characterization of these genes and respective molecular pathways may help the elucidation of the central mechanisms of nicotine action in the brain, as well as indicates potential targets for future studies to the understanding of hypertension models and drug reinforcement associated to tobacco smoking.
The analysis of differentially expressed genes between SHR and WKY brainstem cells after nicotine exposure is of special interest because of the putative function of nicotine on cardiovascular control in animals with genetic background for hypertension as we have reported earlier. 7 In view of this, the interaction between nicotine and the rat strain that evidenced 229 genes (91 decreased in WKY and increased in SHR, and 138 genes increased in WKY and decreased in SHR) is reported in this study.
There are several genes differentially altered between SHR and WKY cells after nicotine exposure that participate in the intracellular trafficking, as showed by the analysis of enriched pathways. In light of the importance of intracellular trafficking and neurotransmission, there are some interesting molecules whose mRNA are differentially expressed and may be important to the understanding of the development of hypertension and other phenotypic differences between the two strains. They include Add3, synapsin III, dynamin 3, kinesin 1Bbeta and piccolo.
Polymorphisms in the gene of Add3 (or gamma-adducin) is suggested to be involved in peripheral mechanisms that lead to hypertension, which make Add3 a potential target for new studies on the hypertension field. 38 This study showed that Add3 may be related to neurogenic hypertension, as brainstem cells from SHR express high levels of this gene as compared with WKY, and the treatment with nicotine acts differently in the two strains. Nicotine augments the expression of Add3 in the WKY and decreases it in SHR.
Synapsin III is associated to synaptic vesicles, in which it participates in the neurotransmission, 39 as well as in cellular body of immature neurons acting on neurogenesis, migration of precursor cells, 40 polarity of neurons and axon differentiation in the central nervous system. 41, 42 Considering that reduction of synapsin III is associated with neurological disorders 43 and the modulator effect of nicotine on synapsins interfering with the release of transmitters, 44 this study showed that reduction of synapsin III by nicotine in cultured brainstem cells may be of importance to the understanding of phenotypic differences between SHR and WKY rats. Dynamin 3 is a molecule that is also involved in intracellular trafficking and recycling of endocytic vesicles especially at the post-synaptic membrane, in which it promotes neurogenesis and synaptogenesis during embryo development. 45, 46 Dynamin 3 mediates intracellular signaling after activation of insulin, neurotrophic factors, epinephrine, glutamate and GABA receptors. [46] [47] [48] [49] In view of this, the results showed an important interaction between nicotine and rat strain for the modulation of dynamin 3, which may be of relevance to understand the development of hypertension and other characteristics that distinguish the central nervous system of SHR and WKY.
Motor protein kinesin 1Bbeta, a product of alternative splicing of kinesin 1B mRNA, is involved in the anterograde transport of synaptic vesicles along the axon. 50 Interestingly, Szolnoki et al, 51 showed that cognitive deficit in hypertensive smokers is related to the presence of polymorphisms in the kinesin gene, which may be related to the findings of this study in which the expression of kinesin 1Bbeta is 70% lower in SHR cells as compared with WKY and nicotine increased it in SHR and decreased it in WKY cells.
In this study, we also showed that piccolo, a protein of the active zone of synapses, is decreased in cultured brainstem cells from prehypertensive SHR as compared with WKY. Moreover, the exposure to nicotine increased the expression of piccolo in SHR and decreased it in WKY cells, which indicates that nicotine may differentially affect neurotransmission in the two strains, as piccolo is involved in neurotransmitter release and internalization of, at least, dopamine receptors. 52, 53 Besides the influence of nicotine combined with the genetic background in the expression of genes related to intracellular events important to neurotransmission, there are also other components more directly related to the neurotransmitter systems, such as GABA receptors, that have their mRNA altered strain-dependent after nicotine exposition.
The participation of GABAergic system in cardiovascular control is well described. Activation of GABAA receptors in the RVLM results in a large fall of mean arterial pressure, heart rate and sympathetic activity. 54 On the other hand, injections of GABAA and GABAB receptors agonists into the NTS produce a pressor response. 55, 56 This study showed for the first time that cultured cells from the medulla oblongata and pons of SHR rats present decreased mRNAs for the GABAA receptor subunit gamma 3 and the multiple coiledcoil GABABR1-binding protein (MGC125215, also called Marlin-1) in comparison with WKY. Nicotine did not change the expression of GABAA receptor subunit gamma 3 and decreased Marlin-1 mRNAs in WKY, but increased their expression in cells from prehypertensive SHR. Marlin-1 associates with the subunit R1 of GABAB receptor to assemble the heterodimer with GABABR2 and also controls GABAB receptor translation at the mRNA level. 57 In view of this, this study suggests that the gabaergic system is altered in the hypertensive strain and may be of relevance to understand the differences in blood pressure levels encountered in SHR and WKY during development. In conclusion, we describe a global gene expression analysis of cultured brainstem cells of newborn SHR and WKY rats in the presence and absence of nicotine that identified genes differentially expressed between strains, within each strain on exposure to nicotine, as well as genes whose modulation by nicotine exposure is strain dependent. It is conceivable that some of the observed nicotine-induced gene expression changes are not related to the development of hypertension or directly mediate the function of nicotine in this pathology, but rather, underlie other phenotypic differences between SHR and WKY rats. Nonetheless, the genes and pathways identified herein constitute interesting candidates that might lead to the development of new therapeutic targets.
